ResMed Inc (RMD) income statement
RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)
Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%
ResMed Inc income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 61.1%
- Operating margin
- 33.0%
- Net margin
- 27.8%
- Return on equity, FY2026
- 24.3%
Financial strength
- Current ratio
- 2.65
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 76.3%
Valuation
- P/E ratio
- 22.1
- Price to sales
- 5.95
- Price to book
- 5.74
- Dividend yield
- 0.99%
See a number that looks wrong?